CHARLESTON, S.C. (AP) — Kobe Sanders scored 27 points, including five of six from the free throw line in the closing minutes, and Nevada pulled away late to beat Oklahoma State 90-78 for a fifth-place finish at the Charleston Classic on Sunday. Nevada's lone loss in its first six games came in the tournament's opening round when the Wolf Pack fell to Vanderbilt 73-71. The Cowboys never led in the contest and Nevada grabbed the lead for good on Justin McBride's tip-in with under 13 minutes left to take a 14-12 lead. Tre Coleman hit two free throws and Chuck Bailey II hit a late jumper to put Nevada up 40-33 at intermission. Abou Ousmane's tip-in at the 5:21 mark got the Cowboys within five, 75-70 but Brandon Love answered with a three-point play seconds later and the Wolf Pack pulled away. Tyler Rolison's 3 with 1:38 left pushed the lead to 84-73. Sanders hit 7 of 10 shots from the field, including 3 of 5 from distance, and was 10 of 13 from the line with three assists and a steal to lead Nevada. Nick Davidson had 23 points on 9 of 16 shooting and Love was a perfect 5-for-5 from the floor and contributed 11 points. The Wolf Pack shot 33 of 56 from the field (58.9%), including 7 of 18 from beyond the arc. Marchelus Avery and Arturo Dean both came off the Oklahoma State bench to score 15 and 13 points, respectively. Robert Jennings II and Ousmane each scored 11 points. Both teams completed the November portion of their schedule. Nevada plays host to Washington State on Dec. 2. Oklahoma State plays at Tulsa on Dec. 4. Get poll alerts and updates on the AP Top 25 throughout the season. Sign up . AP college basketball: andSean “Diddy” Combs’ twin daughters, Jessie and D’Lila Combs, put on a united front over the weekend, attending their high school senior night amidst ongoing legal troubles surrounding their father. The 17-year-olds shared a snapshot on Instagram, beaming in blue-and-white cheerleading uniforms paired with “senior” sashes and tiaras, marking a milestone moment in their young lives. The photo, captioned simply “Senior Night,” showed the twins holding pink pom-poms as they posed on the sidelines of a football game. Their celebratory post was a bright spot in what has otherwise been a difficult few months for the Combs family. Just days earlier, Jessie and D’Lila appeared in a Manhattan courtroom for their father’s third bail hearing . Sean, 55, who remains in custody at a Brooklyn detention center, blew kisses to his daughters and other family members present in the gallery. A judge is expected to decide on his bail within the coming week. The twins have carried on with their senior year activities, determined to find normalcy amid the challenges. Last month, they attended their homecoming, dressed in matching orange off-the-shoulder gowns and bronze heels. Their poised appearances have garnered admiration from fans, who have praised their strength. The sisters also took time earlier this month to honor the memory of their late mother, Kim Porter, who died unexpectedly in 2018. In a heartfelt Instagram tribute marking six years since her passing, they wrote, “We think about you every single second of the day. We love and miss you so much words can’t even explain.” Kim, who shared four children with Sean, was a central figure in their lives, and her absence is deeply felt. Sean, a father of seven, has always been vocal about his pride in his children. Along with Jessie and D’Lila, he shares Quincy, 33, Justin, 30, Christian, 26, Chance, 18, and Love, 2. Despite the serious allegations he faces, his children have publicly stood by him. In October, Sean’s six eldest children attended a court hearing where a May 2025 trial date was set. Following the proceedings, they released a statement defending their father, calling the allegations against him “absurd.” “Many have judged both him and us based on accusations, conspiracy theories, and false narratives that have spiraled into absurdity on social media,” they wrote. “We stand united, supporting you every step of the way. We hold onto the truth, knowing it will prevail, and nothing will break the strength of our family.” Sean’s children have remained a constant source of support during his legal battle, sharing moments of connection with him even from afar. On his birthday, Nov. 4, they called to celebrate with him, a touching exchange that highlighted their close bond. “I just want to say that I’m proud of y’all, especially the girls. I mean, all y’all, just for being strong,” Sean told his kids during the call. The music mogul, who has pleaded not guilty to the charges against him, has maintained his innocence as his legal team prepares for the upcoming trial.STRICTLY Come Dancing fans have been left fuming as another celebrity was sent home in a shock elimination. Tess Daly and Claudia Winkleman presented the results show as week 10 of the competition came to an end. Fans watched as the pair announced Jamie Borthwick and Michelle Tsiakkas would face the dreaded dance off with Montell Douglas and Johannes Radebe. During the show the Sugababes performed a medley of hits Overload, Freak Like Me and Push The Button. Jamie and Michelle performed their foxtrot again, while Montell and Johannes followed with their Quickstep. But in a shock to viewers, Craig Revel Horwood, Anton Du Beke and Motsi Mabuse all chose to save Montell. more on strictly come dancing With the majority vote meaning EastEnders star Jamie was eliminated, head judge Shirley Ballas said she too would have saved Montell. Speaking following the shock result, Jamie said: “Strictly is magic. That is all I can say. Strictly is magic. Not just everyone who you see in front of the camera, these four here [the judges], but everyone who works on this show. "I have such a good bond and relationship with and that's what made me want to do this show, it’s the people, not what I'm doing. I've had the best time. "I could ramble on all day about this one [Michelle]. She's a new pro and she's absolutely been the most amazing teacher. We have laughed like you wouldn’t believe. Most read in News TV "I have nothing but the utmost respect for everyone on the show, so thank you.” Reacting to the result, Strictly fans took to social media, raging how Pete Wicks should have been eliminated. One said: "Seriously people please please stop voting for Pete enough is enough." A second wrote: "Pete Wicks seems like a nice enough chap but I can't believe people are voting for him over Montell." "I love Pete, he's a laugh and he's trying and he's what it's about. But I'm sorry what the f**k," said a third. While a fourth commented: "They will not let Pete near the dance off." STRICTLY Come Dancing's Christmas Special is rolling back around for 2024. Yet who has already scooped the festive Glitterball Trophy? 2005 Darren Gough & Lilia Kopylova 2006 Colin Jackson & Erin Boag 2007 Darren Gough & Lilia Kopylova 2008 Jill Halfpenny & Darren Bennett 2009 Ali Bastian & Brian Fortuna 2010 John Barrowman & Kristina Rihanoff 2011 Charlie Brooks & Vincent Simone 2012 J.B. Gill & Ola Jordan 2013 Rufus Hound & Flavia Cacace 2014 Louis Smith & Aliona Vilani 2015 Harry Judd & Joanne Clifton 2016 Melvin Odoom & Janette Manrara 2017 Katie Derham & Brendan Cole 2018 Aston Merrygold & Janette Manrara 2019 Debbie McGee & Kevin Clifton 2020 — 2021 Anne-Marie & Graziano Di Prima 2022 Alexandra Mardell & Kai Widdrington 2023 Jamie Borthwick & Nancy Xu
BOSTON (AP) — Jaylen Brown scored the Celtics’ first 15 points on five consecutive 3-pointers and finished with 29 points, before Boston withstood a late charge to beat the Minnesota Timberwolves 107-105 on Sunday. Jayson Tatum added 26 points and eight rebounds to help Boston post a season-high fifth straight victory. Anthony Edwards had 28 points and nine rebounds for Minnesota, which has lost five of its last seven. Julius Randle added 23 points, and Rudy Gobert finished with 10 points and 20 rebounds, his eighth double-double of the season. Minnesota got within 55-54 early in the third quarter, before a 14-0 run by Boston. The spurt featured four 3s by the Celtics, including two by Tatum. The lead grew to 79-60 with 4:26 to play in the period. But the Timberwolves chipped it all the way down in the fourth, getting within 107-105 with 34 seconds left on a driving layup by Randle. Timberwolves: Minnesota will be looking to for some wins at home, after dropping four of its last five on the road. Celtics: The Celtics have struggled at home at times this season but improved to 6-2 at the Garden. The Timberwolves had the ball with 7.1 seconds and a chance to win. Edwards got the inbounds and tried to drive on Brown. But he was cut off, and the ball swung to Naz Reid, who failed to get off a 3 as time expired. Boston assisted on 25 of its 37 made field goals. The Timberwolves host Houston in NBA Cup play on Tuesday, beginning a four-game homestand. The Celtics host the Los Angeles Clippers on Monday night. AP NBA: https://apnews.com/hub/nbaIn conclusion, the rapid growth of Dividend ETFs in terms of total scale and leading products breaking through the 20 billion RMB mark is a testament to the increasing popularity and success of these income-focused investment vehicles. As investors continue to embrace the benefits of Dividend ETFs, their role in providing steady income and long-term growth opportunities in investment portfolios is expected to become even more prominent in the future.
In conclusion, the rise of patient capital in the tech sector has ushered in a new era of strategic and long-term investments that are driving innovation and growth. With funds like the one highlighted in this article leading the charge, companies like Semiconductor and Hyper Chips are well-positioned to make significant strides in the semiconductor industry and beyond. As the tech landscape continues to evolve, the role of patient capital will undoubtedly play a crucial role in shaping the future of the industry.
Lululemon Athletica earnings beat by $0.16, revenue topped estimatesSAN RAMON, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal fourth quarter and full year ended October 31, 2024. Fourth quarter 2024 revenue of $1,018.4 million, up 10%, or up 7% organically. Fiscal year 2024 revenue of $3.9 billion, up 8%, or up 8% organically. Fourth quarter 2024 GAAP diluted earnings per share (EPS) of $0.58, up 38%. Fiscal 2024 GAAP diluted EPS of $1.96, up 33%. Fourth quarter 2024 non-GAAP diluted EPS of $1.04, up 19%. Fiscal 2024 non-GAAP diluted EPS of $3.69, up 15%. See "Reconciliation of Selected GAAP Results to Non-GAAP Results" below. Commenting on the results, Al White, Cooper's President and CEO said, "Fiscal 2024 was a great year for Cooper having achieved record consolidated revenues, including record CooperVision revenues, record CooperSurgical revenues and record non-GAAP EPS. We look forward to continued success in fiscal 2025 and thank all of our employees for driving these results." Fourth Quarter Operating Results Revenue of $1,018.4 million, up 10% from last year’s fourth quarter, up 9% in constant currency, up 7% organically. Gross margin of 67% compared with 65% in last year’s fourth quarter driven by price and efficiency gains. On a non-GAAP basis, gross margin was similar to last year at 67%. Operating margin of 19% compared with 15% in last year’s fourth quarter driven by SG&A expense leverage and stronger gross margins. On a non-GAAP basis, operating margin was 26%, up from 24% last year. Interest expense of $27.0 million compared with $26.3 million in last year's fourth quarter. On a non-GAAP basis, interest expense was $25.6 million, down from $26.4 million. Cash provided by operations of $268.1 million offset by capital expenditures of $139.9 million resulted in free cash flow of $128.2 million. Fourth Quarter CooperVision (CVI) Revenue Revenue of $676.4 million, up 9% from last year’s fourth quarter, up 8% in constant currency, up 8% organically. Revenue by category: Revenue by geography: Fourth Quarter CooperSurgical (CSI) Revenue Revenue of $342.0 million, up 12% from last year's fourth quarter, up 12% in constant currency, up 5% organically. Revenue by category: Fiscal Year 2024 Operating Results Revenue of $3,895.4 million, up 8% from fiscal 2023, up 9% in constant currency, up 8% organically. CVI revenue of $2,609.4 million, up 8% from fiscal 2023, up 8% in constant currency, up 9% organically, and CSI revenue $1,286.0 million, up 10% from fiscal 2023, up 11% in constant currency, up 5% organically. Gross margin of 67% compared with 66% in fiscal 2023. Non-GAAP gross margin was 67% compared with 66% in fiscal 2023. Operating margin of 18% compared with 15% in fiscal 2023. Non-GAAP operating margin was 25% compared with 24% in fiscal 2023. Cash provided by operations of $709.3 million offset by capital expenditures of $421.2 million resulted in free cash flow of $288.1 million. Fiscal Year 2025 Financial Guidance The Company initiated its fiscal year 2025 financial guidance. Details are summarized as follows: Fiscal 2025 total revenue of $4,080 - $4,158 million (organic growth of 6% to 8%) CVI revenue of $2,733 - $2,786 million (organic growth of 6.5% to 8.5%) CSI revenue of $1,347 - $1,372 million (organic growth of 4% to 6%) Fiscal 2025 non-GAAP diluted earnings per share of $3.92 - $4.02 Non-GAAP diluted earnings per share guidance excludes amortization and impairment of intangible assets, and certain income or gains and charges or expenses including acquisition and integration costs which we may incur as part of our continuing operations. With respect to the Company’s guidance expectations, the Company has not reconciled non-GAAP diluted earnings per share guidance to GAAP diluted earnings per share due to the inherent difficulty in forecasting acquisition-related, integration and restructuring charges and expenses, which are reconciling items between the non-GAAP and GAAP measures. Due to the unknown effect, timing and potential significance of such charges and expenses that impact GAAP diluted earnings per share, the Company is not able to provide such guidance. Reconciliation of Selected GAAP Results to Non-GAAP Results To supplement our financial results and guidance presented on a GAAP basis, we provide non-GAAP measures such as non-GAAP gross margin, non-GAAP operating margin, non-GAAP diluted earnings per share, as well as constant currency and organic revenue growth because we believe they are helpful for the investors to understand our consolidated operating results. Management uses supplemental non-GAAP financial measures internally to understand, manage and evaluate our business, to make operating decisions, and to plan and forecast for future periods. The non-GAAP measures exclude costs which we generally would not have otherwise incurred in the periods presented as a part of our continuing operations. We provide further details of the non-GAAP adjustments made to arrive at our non-GAAP measures in the GAAP to non-GAAP reconciliations below. Our non-GAAP financial results and guidance are not meant to be considered in isolation or as a substitute for comparable GAAP measures and should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP. To present constant currency revenue growth, current period revenue for entities reporting in currencies other than the United States dollar are converted into United States dollars at the average foreign exchange rates for the corresponding period in the prior year. To present organic revenue growth, we excluded the effect of foreign currency fluctuations and the impact of any acquisitions, divestitures and discontinuations that occurred in the comparable period. We define the non-GAAP measure of free cash flow as cash provided by operating activities less capital expenditures. We believe free cash flow is useful for investors as an additional measure of liquidity because it represents cash that is available to grow the business, make strategic acquisitions, repay debt, or buyback common stock. Management uses free cash flow internally to understand, manage, make operating decisions and evaluate our business. In addition, we use free cash flow to help plan and forecast future periods. Investors should consider non-GAAP financial measures in addition to, and not as replacements for, or superior to, measures of financial performance prepared in accordance with GAAP. EPS, amounts and percentages may not sum or recalculate due to rounding. (1) Charges include the direct effects of acquisition accounting, such as amortization of inventory fair value step-up, professional services fees, regulatory fees and changes in fair value of contingent considerations, and items related to integrating acquired businesses, such as redundant personnel costs for transitional employees, other acquired employee related costs, and integration-related professional services, manufacturing integration costs, legal entity rationalization and other integration-related activities. The acquisition and integration-related charges in fiscal 2024 were primarily related to the Cook Medical acquisition and integration expenses. The acquisition and integration-related charges in fiscal 2023 were primarily related to the Generate acquisition and integration expenses. Charges included $2.9 million and $8.4 million related to redundant personnel costs for transitional employees, $0.7 million and $4.5 million of professional services fees, $1.4 million and $1.4 million of manufacturing integration costs, $1.5 million and 1.5 million of inventory fair value step-up amortization, and $0.7 million and $4.1 million of other acquisition and integration-related activities in the three and twelve months ended October 31, 2024, respectively. The twelve months ended October 31, 2024 also included $0.7 million regulatory fees. Charges included $7.5 million and $21.9 million related to redundant personnel costs for transitional employees, $6.5 million and $16.2 million of professional services fees, $2.9 million and $6.5 million of manufacturing integration costs, $3.1 million and $5.0 million of legal entity rationalization costs, $0.9 million and $2.7 million regulatory fees, and $0.6 million and $5.0 million in other acquisition and integration-related activities, in the three and twelve months ended October 31, 2023, respectively. (2) Charges include costs related to product line exits such as inventory write-offs, site closure costs, contract termination costs and specifically-identified long-lived asset write-offs. Charges included $2.3 million of write-offs of long-lived assets and $1.7 million of other costs related to product line exits in the twelve months October 31, 2024. No charge related to product line exits was incurred in the three months ended October 31, 2024. Charges included $3.4 million and $7.9 million of site closure costs related to the exit of the lens care business, $0.4 million and $1.1 million of other costs related to product line exits in the three and twelve months ended October 31, 2023, respectively. The fourth quarter of fiscal 2023 also included $9.8 million of intangible assets impairment charge associated with the discontinuation of certain products. (3) Charges represent incremental costs of complying with the new European Union (E.U.) medical device regulations for previously registered products and primarily include charges for contractors supporting the project and other direct third-party expenses. We consider these costs to be limited to a specific time period. (4) Charges represent the costs associated with initiatives to increase efficiencies across the organization and optimize our overall cost structure, including changes to our IT infrastructure and operations, employee severance costs, legal entity and other business reorganizations, write-offs or impairments of certain long-lived assets associated with the business optimization activities. Charges included $1.5 million and $10.6 million of employee severance costs, $1.0 million and $4.1 million related to changes to our IT infrastructure and operation, and $0.4 million and $2.9 million of legal entity and other business reorganizations costs, in the three and twelve months ended October 31, 2024, respectively. The twelve months ended October 31, 2024 also included $0.7 million of other optimization costs. Charges included $1.4 million and $11.3 million of employee severance costs, $1.4 million and $1.9 million of legal entity and other business reorganizations costs, and $0.3 million and $5.9 million related to changes to our IT infrastructure and operations, partially offset by $0.2 million and $0.4 million of other items in the three and twelve months ended October 31, 2023, respectively. (5) Amount represents an accrual for probable payment of a termination fee in connection with an asset purchase agreement in the second quarter of 2023, which was paid in August 2023. (6) Amount represents the release the contingent consideration liability associated with SightGlass Vision's regulatory approval milestone in the first quarter of 2023. (7) Charges include certain business disruptions from natural causes, litigation matters and other items that are not part of ordinary operations. The adjustments to arrive at non-GAAP net income also include gains and losses on minority interest investments and accretion of interest attributable to acquisition installment payables. Charges included $1.5 million and $5.9 million of gains and losses on minority interest investments, $1.4 million and $5.5 million of accretion of interest attributable to acquisition installments payable, $0.6 million and $1.5 million related to legal matters in the three and twelve months ended October 31, 2024, respectively. Charges included $1.6 million and $6.3 million of gains and losses on minority interest investments, and $1.3 million and $4.6 million related to legal matters in the three and twelve months ended October 31, 2023, respectively. The twelve months ended October 31, 2023 also included $1.1 million of other items. (8) In fiscal 2021, the Company transferred its CooperVision intellectual property and goodwill to its UK subsidiary. As a result, we recorded a deferred tax asset equal to approximately $2.0 billion as a one-time tax benefit in accordance with U.S. GAAP in fiscal 2021 as subsequently adjusted for changes in UK tax law. The non-GAAP adjustments reflect the ongoing net deferred tax benefit from tax amortization each period under UK tax law. Audio Webcast and Conference Call The Company will host an audio webcast today for the public, investors, analysts and news media to discuss its fourth quarter results and current corporate developments. The audio webcast will be broadcast live on CooperCompanies' website, www.investor.coopercos.com , at approximately 5:00 PM ET. It will also be available for replay on CooperCompanies' website, www.investor.coopercos.com . Alternatively, you can dial in to the conference call at 800-715-9871; conference ID 2026064. About CooperCompanies CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on improving lives one person at a time. The Company operates through two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, improving the vision of millions of people every day. CooperSurgical is a leading fertility and women's health company dedicated to assisting women, babies and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies ("Cooper") has a workforce of more than 16,000 with products sold in over 130 countries. For more information, please visit www.coopercos.com. Forward-Looking Statements This earnings release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Statements relating to guidance, plans, prospects, goals, strategies, future actions, events or performance and other statements of which are other than statements of historical fact, including our fiscal year 2025 financial guidance are forward looking. In addition, all statements regarding anticipated growth in our revenues, anticipated effects of any product recalls, anticipated market conditions, planned product launches, restructuring or business transition expectations, regulatory plans, and expected results of operations and integration of any acquisition are forward-looking. To identify these statements look for words like "believes," "outlook," "probable," "expects," "may," "will," "should," "could," "seeks," "intends," "plans," "estimates" or "anticipates" and similar words or phrases. Forward-looking statements necessarily depend on assumptions, data or methods that may be incorrect or imprecise and are subject to risks and uncertainties. Among the factors that could cause our actual results and future actions to differ materially from those described in forward-looking statements are: adverse changes in the global or regional general business, political and economic conditions including the impact of continuing uncertainty and instability of certain countries, man-made or natural disasters and pandemic conditions, that could adversely affect our global markets, and the potential adverse economic impact and related uncertainty caused by these items; the impact of international conflicts and the global response to international conflicts on the global and local economy, financial markets, energy markets, currency rates and our ability to supply product to, or through, affected countries; our substantial and expanding international operations and the challenges of managing an organization spread throughout multiple countries and complying with a variety of legal, compliance and regulatory requirements; foreign currency exchange rate and interest rate fluctuations including the risk of fluctuations in the value of foreign currencies or interest rates that would decrease our net sales and earnings; our existing and future variable rate indebtedness and associated interest expense is impacted by rate increases, which could adversely affect our financial health or limit our ability to borrow additional funds; changes in tax laws, examinations by tax authorities, and changes in our geographic composition of income; acquisition-related adverse effects including the failure to successfully achieve the anticipated net sales, margins and earnings benefits of acquisitions, integration delays or costs and the requirement to record significant adjustments to the preliminary fair value of assets acquired and liabilities assumed within the measurement period, required regulatory approvals for an acquisition not being obtained or being delayed or subject to conditions that are not anticipated, adverse impacts of changes to accounting controls and reporting procedures, contingent liabilities or indemnification obligations, increased leverage and lack of access to available financing (including financing for the acquisition or refinancing of debt owed by us on a timely basis and on reasonable terms); compliance costs and potential liability in connection with U.S. and foreign laws and health care regulations pertaining to privacy and security of personal information such as the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and the California Consumer Privacy Act (CCPA) in the U.S. and the General Data Protection Regulation (GDPR) requirements in Europe, including but not limited to those resulting from data security breaches; a major disruption in the operations of our manufacturing, accounting and financial reporting, research and development, distribution facilities or raw material supply chain due to challenges associated with integration of acquisitions, man-made or natural disasters, pandemic conditions, cybersecurity incidents or other causes; a major disruption in the operations of our manufacturing, accounting and financial reporting, research and development or distribution facilities due to the failure to perform by third-party vendors, including cloud computing providers or other technological problems, including any related to our information systems maintenance, enhancements or new system deployments, integrations or upgrades; a successful cybersecurity attack which could interrupt or disrupt our information technology systems, or those of our third-party service providers, or cause the loss of confidential or protected data; market consolidation of large customers globally through mergers or acquisitions resulting in a larger proportion or concentration of our business being derived from fewer customers; disruptions in supplies of raw materials, particularly components used to manufacture our silicone hydrogel lenses; new U.S. and foreign government laws and regulations, and changes in existing laws, regulations and enforcement guidance, which affect areas of our operations including, but not limited to, those affecting the health care industry, including the contact lens industry specifically and the medical device or pharmaceutical industries generally, including but not limited to the EU Medical Devices Regulation (MDR), and the EU In Vitro Diagnostic Medical Devices Regulation (IVDR); legal costs, insurance expenses, settlement costs and the risk of an adverse decision, prohibitive injunction or settlement related to product liability, patent infringement, contractual disputes, or other litigation; limitations on sales following product introductions due to poor market acceptance; new competitors, product innovations or technologies, including but not limited to, technological advances by competitors, new products and patents attained by competitors, and competitors' expansion through acquisitions; reduced sales, loss of customers, reputational harm and costs and expenses, including from claims and litigation related to product recalls and warning letters; failure to receive, or delays in receiving, regulatory approvals or certifications for products; failure of our customers and end users to obtain adequate coverage and reimbursement from third-party payers for our products and services; the requirement to provide for a significant liability or to write off, or accelerate depreciation on, a significant asset, including goodwill, other intangible assets and idle manufacturing facilities and equipment; the success of our research and development activities and other start-up projects; dilution to earnings per share from acquisitions or issuing stock; impact and costs incurred from changes in accounting standards and policies; risks related to environmental laws and requirements applicable to our facilities, products or manufacturing processes, including evolving regulations regarding the use of hazardous substances or chemicals in our products; risks related to environmental, social and corporate governance (ESG) issues, including those related to regulatory and disclosure requirements, climate change and sustainability; and other events described in our Securities and Exchange Commission filings, including the “Business”, “Risk Factors” and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections in the Company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2024, as such Risk Factors may be updated in annual and quarterly filings. We caution investors that forward-looking statements reflect our analysis only on their stated date. We disclaim any intent to update them except as required by law. Contact: Kim Duncan Vice President, Investor Relations and Risk Management 925-460-3663 ir@cooperco.com THE COOPER COMPANIES, INC. AND SUBSIDIARIES GAAP to Non-GAAP Reconciliation Constant Currency Revenue Growth and Organic Revenue Growth Net SalesExcitement fills the air as investors around the world eagerly anticipate the opening of the A-share market, following the news that the Golden Dragon Index has soared back to the 7000-point mark. The jubilant atmosphere is palpable, with traders and analysts alike celebrating the milestone that signals a resurgence in confidence and optimism in the stock market.
None
As consumers of online content, we have a responsibility to be discerning and critical of the content we choose to engage with. Supporting and promoting individuals who engage in lewd and inappropriate behavior only perpetuates a culture of toxicity and enables further exploitation for the sake of entertainment. By holding internet celebrities and influencers accountable for their actions, we can create a safer and more respectful online environment for all users.As the investigation into the attack continues, questions linger about the motives behind the targeted violence and the failure of authorities to prevent such a tragedy. Calls for greater security measures and improved social services have grown louder as the community demands justice for the victims and protection for the vulnerable.